A Salen-Manganese Catalytic Free Radical Scavenger Inhibits Type 1 Diabetes and Islet Allograft Rejection
- Angelica P. Olcott1,
- Georges Tocco2,
- Jide Tian1,
- Dan Zekzer1,
- Jon Fukuto1,
- Louis Ignarro1 and
- Daniel L. Kaufman1
- 1Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California
- 2Harvard Medical School, Boston, Massachusetts
- Address correspondence and reprint requests to Daniel L. Kaufman, Department of Molecular and Medical Pharmacology, UCLA School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1735. E-mail: dkaufman{at}mednet.ucla.edu
Abstract
Reactive oxygen species, such as superoxide, and nitrogen oxides, such as peroxynitrite, are thought to contribute to β-cell destruction during the disease process that leads to type 1 diabetes. EUK-8 is a member of a new class of synthetic salen-manganese compounds with low toxicity that possess catalytic superoxide dismutase, peroxidase, and catalase activity that can inactivate superoxide and nitrogen oxides (e.g., peroxynitrite and nitrogen dioxide). We observed that EUK-8 administration inhibited the adoptive transfer of type 1 diabetes to NOD mice. In addition, administration of EUK-8 to NOD mice with established autoimmunity completely prevented the development of type 1 diabetes for up to 1 year in age, even though the treatment was discontinued after 35 weeks of age. EUK-8 treatment also prolonged the survival of islet allografts in newly diabetic NOD mice. Thus, reactive oxygen and nitrogen species contribute to the pathoetiology of both spontaneous type 1 diabetes and allograft rejection. In cultures of NIT-1 cells, EUK-8 inhibited cytotoxicity caused by superoxide as well as nitric oxide. Collectively, our findings implicate a greater role for nitrogen oxides (other than peroxynitrite) in β-cell damage. Antioxidants designed to prevent the formation of both cytotoxic reactive oxygen and nitrogen species may effectively protect β-cells from spontaneous autoimmunity and alloresponses.
- DETA-NONOate, (Z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate
- EAE, experimental autoimmune encephalomyelitis
- RNS, reactive nitrogen species
- ROS, reactive oxygen species
- SIN-1, 3-morpholinosydnonimine-N-ethylcarbamide
- SOD, superoxide dismutase
Footnotes
-
G.T. holds stock in Eukarion.
-
- Accepted July 14, 2004.
- Received May 3, 2004.
- DIABETES











